BrightInsight and Headspace Partner to Pair Mental Health Support with Treatment Adherence

BrightInsight brings Headspace’s curated mental-health content into its patient persistence solution, matched to each patient's condition and activated at the moments that decide whether patients stay on therapy


SAN JOSE, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- BrightInsight, the digital one-stop shop for patient support trusted by the world's largest biopharma brands across 60+ countries, today announced a partnership with Headspace, the leading mental health companion for everyday support. The partnership builds Headspace’s mental health services into the program experience, curated for each patient's condition and surfaced when they need them most.

Fewer than 1 in 3 patients who start therapy are still on it at 12 months, and the industry loses more than $500B globally to patient drop-off every year. One of the least-addressed reasons is not clinical or financial, it's psychological. Anxiety, isolation and feeling overwhelmed pull patients off treatment that’s working. BrightInsight and Headspace are joining forces to better bridge that gap.

BrightInsight unifies a normally fragmented set of programs, education, adherence support, savings and clinical touchpoints, into one connected experience, then surfaces the right support the moment each patient needs it. Mental health is a well-documented driver of whether patients stay on treatment: patients experiencing depression are nearly twice as likely to stop taking their medication as prescribed 1. A curated library of Headspace content plugs into that experience, not a separate app for a patient to remember, orchestrated alongside everything patients rely on to stay on therapy.

That support shows up at the two moments that matter. From the start, patients get help to begin therapy confidently. And when a patient misses a dose or engagement slips, BrightInsight responds with the right Headspace support, every interaction tied back to whether the patient stays on therapy.

For patients whose therapy depends on a caregiver, support extends to them too, the person whose capacity often determines whether treatment continues.

"We can predict the adherence challenges a patient is likely to face and intervene proactively, with the right support at the right moment," said Kal Patel, CEO of BrightInsight. "This partnership adds the power of Headspace to that arsenal. When what stands between a patient and their therapy is anxiety or overwhelm, we can meet it with mental health support that patients already trust in the same connected experience as everything else BrightInsight does for them."

"We've always believed mental health support should meet people in the moments they need it most,” said Dr. Jon Kole, Medical Director at Headspace. “Staying on treatment is never only about the medication. It's about whether someone has support within reach at the hardest points in their journey, and whether they have to go looking for it. Building that access into the patient experience is how we help people keep going.”

BrightInsight's impact on persistence is already proven. In an analysis run by a global pharma partner across a real-world dataset of more than 60,000 patients, 13% more patients stayed on therapy at 12 months than those in traditional patient support programs, a statistically significant result drawn from over 6,000 patients evaluated across three cohorts. Adding Headspace's curated mental-health content is designed to build on that impact.

The partnership is available now to BrightInsight's pharma and biotech customers, built to safety, privacy and quality standards regulated markets demand worldwide.

About BrightInsight:
BrightInsight is the patient persistence solution built exclusively to improve adherence and persistence. With fewer than 1 in 3 patients still on novel therapy at 12 months, drop-off steals health from patients and $500B+ in value from brands every year. BrightInsight closes the gap existing systems were never designed to fill, unifying signals, programs and interventions into one connected experience that keeps patients on therapy longer, compounding both value and health outcomes. For more information, visit BrightInsight.com.

About Headspace
Headspace is an everyday mental health companion, helping millions of people around the world care for their mind, build resilience, and improve their wellbeing. The app, which has been downloaded over 105M times across 190 countries, provides personalized mindfulness, sleep and mental health support designed to fit seamlessly into daily life. We partner with over 4,000 employers, 45 health plans, and other organizations to extend evidence-based care to their communities, offering additional services including EAP, care navigation, psychiatry, and work-life resources. Our team is made up of world-class clinicians, researchers, Emmy Award-winning storytellers, and AI experts, working together to provide every person access to lifelong mental health support. In a busy, complicated world, Headspace is here to remind you: your mind matters. Learn more at headspace.com.

Media contacts
BrightInsight: Media, media@brightinsight.com 
Headspace: Press team, press@headspace.com

1 Grenard et al., J Gen Intern Med, 2011



GlobeNewswire